Rising Biosciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications
August 02 2017 - 12:28PM
InvestorsHub NewsWire
New York, NY -- August 02, 2017 -- InvestorsHub NewsWire --
Rising Indias (OTC: RSII) Rising Biosciences, Inc., a research and development
company focusing on oral and topical pharmaceuticals with strict
standards set forward by the pharmaceutical compounding industry,
announces that the Company has entered in the FDA testing phase on
its revolutionary medical creams for chronic pain relief and
neuropathic pain.
These two pain creams will be the first in a series of products.
Rising Biosciences, Inc. has retained an industrys leading
formulator and manufacturer of scientifically proven,
innovative personal care products in anticipation for its testing
phase of a full suite of OTC (over-the-counter) chronic pain relief
medications for neuropathy, muscle and tendon pain, arthritis, and
treatment, as well as its skin serum for scars, wrinkles and
stretch marks.
Doug Bowes, Director of Brand Development for Rising Biosciences
states, Our partnering facility is an ISO 22716 Certified, cGMP
compliant, and FDA Registered factory that utilizes the latest in
technological equipment to manufacture products as quickly as
possible, under the highest quality standards. Our team
works in a state-of-the-art, in-house laboratory, and highly
experienced chemists for advanced formulation and
manufacturing.
Product samples shipped to dozens of recipients on June 13, 2017
and the feedback continues to be overwhelmingly positive, states
CEO Robert Weber. We cant help be excited for the future for Rising
BioSciences and its shareholders. With a finalized merger and
products undergoing testing for FDA approval, we are on the cusp of
delivering effective, non-opiate medication nationwide; using
alternative medicine, including both Cannabis and non-Cannabis
based solutions.
We are assertively driving the Company toward monetization with
initiatives to distribute the first two products in Q4 2017. All
the while well be running testing and manufacturing details on
subsequent products in our pain relief and skin serum lines.
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news
release may contain forward-looking information within the meaning
of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under
the Securities Exchange Act of 1934, and are subject to the safe
harbor created by those rules. All statements, other than
statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements. Technical complications, which may arise, could
prevent the prompt implementation of any strategically significant
plan(s) outlined above. The Company undertakes no duty to revise or
update any forward- looking statements to reflect events or
circumstances after the date of this release.
Rising Biosciences (CE) (USOTC:RBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rising Biosciences (CE) (USOTC:RBII)
Historical Stock Chart
From Sep 2023 to Sep 2024